Literature DB >> 9119485

Conservation of the 15-kilodalton lipoprotein among Treponema pallidum subspecies and strains and other pathogenic treponemes: genetic and antigenic analyses.

A Centurion-Lara1, T Arroll, R Castillo, J M Shaffer, C Castro, W C Van Voorhis, S A Lukehart.   

Abstract

The 15-kDa lipoprotein of Treponema pallidum is a major immunogen during natural syphilis infection in humans and experimental infection in other hosts. The humoral and cellular immune responses to this molecule appear late in infection as resistance to reinfection is developing. One therefore might hypothesize that this antigen is important for protective immunity. This possibility is explored by using both genetic and antigenic approaches. Limited or no cross-protection has been demonstrated between the T. pallidum subspecies and strains or between Treponema species. We therefore hypothesized that if the 15-kDa antigen was of major importance in protective immunity, it might be a likely site of antigenic diversity. To explore this possibility, the sequences of the open reading frames of the 15-kDa gene have been determined for Treponema pallidum subsp. pallidum (Nichols and Bal-3 strains), T. pallidum subsp. pertenue (Gauthier strain), T. pallidum subsp. endemicum (Bosnia strain), Treponema paraluiscuniculi (Cuniculi A, H, and K strains), and a little-characterized simian isolate of Treponema sp. (Fribourg-Blanc strain). No significant differences in DNA sequences of the genes for the coding region of the 15-kDa antigen were found among the different species and subspecies studied. In addition, all organisms showed expression of the 15-kDa antigen as determined by monoclonal antibody staining. The role of the 15-kDa antigen in protection against homologous infection with T. pallidum subsp. pallidum Nichols was examined in rabbits immunized with a purified recombinant 15-kDa fusion protein. No alteration in chancre development was observed in immunized, compared to unimmunized, rabbits, and the antisera induced by the immunization failed to enhance phagocytosis of T. pallidum subsp. pallidum by macrophages in vitro. These results do not support a major role for this antigen in protection against syphilis infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119485      PMCID: PMC175151          DOI: 10.1128/iai.65.4.1440-1444.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  [NOTE ON SOME IMMUNOLOGICAL ASPECTS OF THE AFRICAN CYNOCEPHALUS. 1. ANTIGENIC RELATIONSHIP OF ITS GAMMA GLOBULIN WITH HUMAN GAMMA GLOBULIN. 2. GUINEAN ENDEMIC FOCUS OF TREPONEMATOSIS].

Authors:  A FRIBOURG-BLANC; G NIEL; H H MOLLARET
Journal:  Bull Soc Pathol Exot Filiales       Date:  1963 May-Jun

2.  Lipid modification of the 15 kiloDalton major membrane immunogen of Treponema pallidum.

Authors:  B K Purcell; M A Swancutt; J D Radolf
Journal:  Mol Microbiol       Date:  1990-08       Impact factor: 3.501

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.

Authors:  N H Bishop; J N Miller
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

5.  The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum.

Authors:  D L Cox; P Chang; A W McDowall; J D Radolf
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Demonstration of the in vitro phagocytosis of Treponema pallidum by rabbit peritoneal macrophages.

Authors:  S A Lukehart; J N Miller
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

7.  Isolation of the outer membranes from Treponema pallidum and Treponema vincentii.

Authors:  D R Blanco; K Reimann; J Skare; C I Champion; D Foley; M M Exner; R E Hancock; J N Miller; M A Lovett
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

8.  Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct.

Authors:  J D Radolf; M V Norgard; M E Brandt; R D Isaacs; P A Thompson; B Beutler
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

Review 9.  Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.

Authors:  S J Norris
Journal:  Microbiol Rev       Date:  1993-09

10.  Treponema pallidum in gel microdroplets: a novel strategy for investigation of treponemal molecular architecture.

Authors:  D L Cox; D R Akins; S F Porcella; M V Norgard; J D Radolf
Journal:  Mol Microbiol       Date:  1995-03       Impact factor: 3.501

View more
  15 in total

1.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Quantitative assessment of protection in experimental syphilis.

Authors:  Cheryl I Champion; David R Blanco; Michael A Lovett
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 4.  The endemic treponematoses.

Authors:  Lorenzo Giacani; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

5.  Genetic and structural analyses of cytoplasmic filaments of wild-type Treponema phagedenis and a flagellar filament-deficient mutant.

Authors:  J Izard; W A Samsonoff; M B Kinoshita; R J Limberger
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

Review 6.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

7.  Multiple alleles of Treponema pallidum repeat gene D in Treponema pallidum isolates.

Authors:  A Centurion-Lara; E S Sun; L K Barrett; C Castro; S A Lukehart; W C Van Voorhis
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

8.  A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum.

Authors:  David R Blanco; Cheryl I Champion; Alek Dooley; David L Cox; Julian P Whitelegge; Kym Faull; Michael A Lovett
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

9.  Quantitative analysis of tpr gene expression in Treponema pallidum isolates: Differences among isolates and correlation with T-cell responsiveness in experimental syphilis.

Authors:  Lorenzo Giacani; Barbara Molini; Charmie Godornes; Lynn Barrett; Wesley Van Voorhis; Arturo Centurion-Lara; Sheila A Lukehart
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

10.  The sequence-variable, single-copy tprK gene of Treponema pallidum Nichols strain UNC and Street strain 14 encodes heterogeneous TprK proteins.

Authors:  L V Stamm; H L Bergen
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.